Acadia Healthcare Company (ACHC) EBITDA Margin (2016 - 2025)
Acadia Healthcare Company (ACHC) has disclosed EBITDA Margin for 15 consecutive years, with 163.79% as the latest value for Q4 2025.
- On a quarterly basis, EBITDA Margin fell 19585.0% to 163.79% in Q4 2025 year-over-year; TTM through Dec 2025 was 48.88%, a 5876.0% decrease, with the full-year FY2025 number at 1.05%, down 1306.0% from a year prior.
- EBITDA Margin was 163.79% for Q4 2025 at Acadia Healthcare Company, down from 32.92% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 32.06% in Q4 2024 to a low of 163.79% in Q4 2025.
- A 5-year average of 9.64% and a median of 0.64% in 2022 define the central range for EBITDA Margin.
- Peak YoY movement for EBITDA Margin: skyrocketed 6062bps in 2024, then crashed -19585bps in 2025.
- Acadia Healthcare Company's EBITDA Margin stood at 2.87% in 2021, then crashed by -736bps to 18.29% in 2022, then surged by 139bps to 7.17% in 2023, then surged by 347bps to 32.06% in 2024, then tumbled by -611bps to 163.79% in 2025.
- Per Business Quant, the three most recent readings for ACHC's EBITDA Margin are 163.79% (Q4 2025), 32.92% (Q3 2025), and 2.47% (Q2 2025).